FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely hepatology and vascular surgery, and concerns treating and preventing venous thromboembolic complications (VTEC). That is ensured by adding the integrated treatment of VTEC with the preparation 'Angiovit' 1 tablet twice a day for 6-12 months. Then 2-4, 6-8 and 10-12 months later, blood serum homocysteine is tested, and if the value is less than 11.0 mcmole/l, the supporting therapy with Angiovit 1 tablet once a day for 6 months is prescribed.
EFFECT: preparation dose schedule provides the effective treatment and prevention of the recurrent VTEC ensured by normalising and maintaining patient's normal homocysteine level.
1 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTING DEVELOPMENT OF POST-OPERATIVE VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH COLORECTAL CANCER | 2014 |
|
RU2554803C1 |
| PREPARATION FOR TREATING AND PREVENTING ATHEROSCLEROSIS | 2003 |
|
RU2287327C2 |
| BIOLOGICALLY ACTIVE SUPPLEMENT "VITABS KARDIO" FOR PROPHYLAXIS OF CARDIOVASCULAR DISEASE | 2005 |
|
RU2312674C2 |
| METHOD OF CONSERVATIVE TREATMENT OF RECURRENT HAEMOPHTHALMIA IN DIABETIC RETINOPATHY | 2012 |
|
RU2485944C1 |
| THERAPY OF HYPERHOMOCYSTEINEMIA | 2007 |
|
RU2360706C2 |
| METHOD FOR CORRECTING REPRODUCTIVE HEALTH IN FEMALES | 2006 |
|
RU2314094C1 |
| METHOD FOR THE ETIOPATHOGENETIC TREATMENT OF PARAVASAL DISORDERS OF BULBAR CONJUNCTIVA IN PATIENTS WITH COVID-19 ASSOCIATED PNEUMONIA | 2021 |
|
RU2760297C1 |
| METHOD FOR EVALUATING ISCHEMIC STROKE SEVERITY DEGREE IN PEOPLE BEING NOT MORE THAN 50 YEARS OLD | 2005 |
|
RU2312356C2 |
| ORAL THERAPY OF VITAMIN B DEFICIENCY | 2011 |
|
RU2576511C2 |
| METHOD OF TAKING RISK ASSESSMENT OF DEVELOPMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN WOUNDED AND INJURED PEOPLE | 2016 |
|
RU2657196C2 |
